Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-26-034503
Filing Date
2026-03-25
Accepted
2026-03-25 16:03:45
Documents
2
Period of Report
2026-03-18

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm268906-8_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm268906-8_3seq1.xml 3 4203
2 EXHIBIT 24 tm268906d8_ex24.htm EX-24 8219
  Complete submission text file 0001104659-26-034503.txt   13852
Mailing Address C/O ENTERIN, INC. 2005 MARKET STREET, SUITE 3125 PHILADELPHIA PA 19103
Business Address
Mills Roger (Reporting) CIK: 0001368190 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39179 | Film No.: 26792396

Mailing Address CHEMIN DES MINES 9 GENEVA V8 CH-1202
Business Address CHEMIN DES MINES 9 GENEVA V8 CH-1202 01141228841555
Addex Therapeutics Ltd. (Issuer) CIK: 0001574232 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)